Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene–environment interactions

[1]  J. Sutcliffe,et al.  Analysis of the RELN gene as a genetic risk factor for autism , 2005, Molecular Psychiatry.

[2]  David A. Pearce,et al.  Reelin signaling is impaired in autism , 2005, Biological Psychiatry.

[3]  S. Fatemi,et al.  Reelin glycoprotein: structure, biology and roles in health and disease , 2005, Molecular Psychiatry.

[4]  J. Danesh,et al.  Paraoxonase polymorphisms and coronary heart disease , 2004, The Lancet.

[5]  D. Rabinowitz,et al.  Enhanced APOE2 transmission rates in families with autistic probands , 2004, Psychiatric genetics.

[6]  G. Dawson,et al.  Alleles of a reelin CGG repeat do not convey liability to autism in a sample from the CPEA network , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[7]  L. Lotspeich,et al.  Lack of evidence for an association between WNT2 and RELN polymorphisms and autism , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[8]  Alessandro Quattrone,et al.  Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism , 2004, Biological Psychiatry.

[9]  Xin Xu,et al.  Family‐based tests for associating haplotypes with general phenotype data: Application to asthma genetics , 2004, Genetic epidemiology.

[10]  T. Slotkin,et al.  Developmental exposure to chlorpyrifos elicits sex-selective alterations of serotonergic synaptic function in adulthood: critical periods and regional selectivity for effects on the serotonin transporter, receptor subtypes, and cell signaling. , 2003, Environmental health perspectives.

[11]  T. Slotkin,et al.  Serotonergic systems targeted by developmental exposure to chlorpyrifos: effects during different critical periods. , 2003, Environmental health perspectives.

[12]  S. Klauck,et al.  Analysis of reelin as a candidate gene for autism , 2003, Molecular Psychiatry.

[13]  L. Ricceri,et al.  Developmental exposure to chlorpyrifos alters reactivity to environmental and social cues in adolescent mice. , 2003, Toxicology and applied pharmacology.

[14]  John M. Davis,et al.  Methodological factors influencing measurement and processing of plasma reelin in humans , 2003, BMC Biochemistry.

[15]  Flavio Keller,et al.  The neurobiological context of autism , 2003, Molecular Neurobiology.

[16]  A. Tward,et al.  Expression of human paraoxonase (PON1) during development. , 2003, Pharmacogenetics.

[17]  Jia Chen,et al.  Increased influence of genetic variation on PON1 activity in neonates. , 2003, Environmental health perspectives.

[18]  J. Chuang,et al.  Aggregate exposures of nine preschool children to persistent organic pollutants at day care and at home , 2003, Journal of Exposure Analysis and Environmental Epidemiology.

[19]  F. Perera,et al.  Contemporary-use pesticides in personal air samples during pregnancy and blood samples at delivery among urban minority mothers and newborns. , 2002, Environmental health perspectives.

[20]  T. Slotkin,et al.  Fetal chlorpyrifos exposure: adverse effects on brain cell development and cholinergic biomarkers emerge postnatally and continue into adolescence and adulthood. , 2002, Environmental health perspectives.

[21]  F. Perera,et al.  Residential pesticide use during pregnancy among a cohort of urban minority women. , 2002, Environmental health perspectives.

[22]  Flavio Keller,et al.  Reelin Is a Serine Protease of the Extracellular Matrix* , 2002, The Journal of Biological Chemistry.

[23]  S. Folstein,et al.  Genetics of austim: complex aetiology for a heterogeneous disorder , 2001, Nature Reviews Genetics.

[24]  E. Nikolaidis,et al.  Inhibition of rat platelet 5-hydroxytryptamine uptake by chlorpyrifos and carbaryl. , 2001, Pharmacology & toxicology.

[25]  S. Spence,et al.  The autism genetic resource exchange: a resource for the study of autism and related neuropsychiatric conditions. , 2001, American journal of human genetics.

[26]  G. Jarvik,et al.  Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. , 2001, American journal of human genetics.

[27]  J. Dambrosia,et al.  Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation , 2001, Annals of neurology.

[28]  Axel Benner,et al.  Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q. , 2001, Human molecular genetics.

[29]  N. Laird,et al.  The family based association test method: strategies for studying general genotype–phenotype associations , 2001, European Journal of Human Genetics.

[30]  D. Barr,et al.  Measurement of organophosphate metabolites in postpartum meconium as a potential biomarker of prenatal exposure: a validation study. , 2001, Environmental health perspectives.

[31]  T. Wassink,et al.  Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder , 2001, Molecular Psychiatry.

[32]  Antonio F. Hernández,et al.  Hydrolysis of platelet-activating factor by human serum paraoxonase. , 2001, The Biochemical journal.

[33]  A. Tward,et al.  Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. , 2000, Pharmacogenetics.

[34]  G. Schellenberg,et al.  Paraoxonase (PON1) Phenotype Is a Better Predictor of Vascular Disease Than Is PON1192 or PON155 Genotype , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[35]  F. Muratori,et al.  Increased density of the platelet serotonin transporter in autism. , 2000, Pharmacopsychiatry.

[36]  C. Aprea,et al.  Biologic monitoring of exposure to organophosphorus pesticides in 195 Italian children. , 2000, Environmental health perspectives.

[37]  I. Leviev,et al.  Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[38]  C. Furlong,et al.  Determination of paraoxonase (PON1) status requires more than genotyping. , 1999, Pharmacogenetics.

[39]  Maurizio Elia,et al.  Sulphation deficit in “low-functioning” autistic children: a pilot study , 1999, Biological Psychiatry.

[40]  L Claudio,et al.  Pesticides and inner-city children: exposures, risks, and prevention. , 1999, Environmental health perspectives.

[41]  T. Standiford,et al.  On the physiological role(s) of the paraoxonases. , 1999, Chemico-biological interactions.

[42]  D. Shih,et al.  The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism. , 1999, Chemico-biological interactions.

[43]  C. Aprea,et al.  Reference values of urinary 3,5,6-trichloro-2-pyridinol in the Italian population--validation of analytical method and preliminary results (multicentric study). , 1999, Journal of AOAC International.

[44]  M Knapp,et al.  The transmission/disequilibrium test and parental-genotype reconstruction: the reconstruction-combined transmission/ disequilibrium test. , 1999, American journal of human genetics.

[45]  P. Teitelbaum,et al.  Movement analysis in infancy may be useful for early diagnosis of autism. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. O’Donovan,et al.  Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. , 1998, Genomics.

[47]  T. Slotkin,et al.  Developmental neurotoxicity of chlorpyrifos: delayed targeting of DNA synthesis after repeated administration. , 1998, Brain research. Developmental brain research.

[48]  Eric Courchesne,et al.  Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism , 1997, Current Opinion in Neurobiology.

[49]  C. Heijnen,et al.  Autism and the immune system. , 1997, Journal of child psychology and psychiatry, and allied disciplines.

[50]  W J Ewens,et al.  The TDT and other family-based tests for linkage disequilibrium and association. , 1996, American journal of human genetics.

[51]  C. Barthélémy,et al.  Serotonin and autism: Biochemical and molecular biology features , 1996, Psychiatry Research.

[52]  E. Green,et al.  Structural organization of the human PON1 gene. , 1996, Genomics.

[53]  P. Rodier,et al.  Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei , 1996, The Journal of comparative neurology.

[54]  R H Hill,et al.  Pesticide residues in urine of adults living in the United States: reference range concentrations. , 1995, Environmental research.

[55]  P Bolton,et al.  Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: a twin and family history study of autism. , 1995, American journal of human genetics.

[56]  J. Long,et al.  An E-M algorithm and testing strategy for multiple-locus haplotypes. , 1995, American journal of human genetics.

[57]  S. Folstein,et al.  Platelet serotonin, a possible marker for familial autism , 1991, Journal of autism and developmental disorders.

[58]  B. Leventhal,et al.  Free serotonin in plasma: Autistic children and their first-degree relatives , 1988, Biological Psychiatry.

[59]  M. Okuda,et al.  Kinetics of3H-Serotonin uptake by platelets in infantile autism and developmental language disorder (including five pairs of twins) , 1986, Journal of Autism and Developmental Disorders.

[60]  A. Persico,et al.  Serotonin transporter gene promoter variants do not explain the hyperserotoninemia in autistic children , 2002, Molecular Psychiatry.

[61]  C. Gillberg,et al.  Absence of association between a polymorphic GGC repeat in the 5′ untranslated region of the reelin gene and autism , 2002, Molecular Psychiatry.

[62]  D. Grayson,et al.  Reelin gene alleles and susceptibility to autism spectrum disorders , 2002, Molecular Psychiatry.

[63]  D. Adler,et al.  The molecular basis of the human serum paraoxonase activity polymorphism , 1993, Nature Genetics.